Showing 11 of 11 results

Chair Kathleen Neuzil
2:00 - Salmonella typhi, Sushant Sahastrabuddhe, IVI. 20:32 - Schistosomiasis, Robert Bergquist, Geospatial Health. 36:26 - HPV, Aimee Kreimer, NCI/NIH. 52:46 - Novel OPV, Ananda Bandyopadhyay,...
Sushant Sahastrabuddhe, International Vaccine Institute
Landscape of typhoid conjugate vaccines, next steps and challenges. Rationale and landscape for non-typhoidal salmonella vaccines.
Robert Bergquist, Geospatial Health
Key arguments for schistosomiasis vaccine development and update on vaccine candidates
Melissa Kapulu, KEMRI-Wellcome Trust Research Programme
Role of CHMI in malaria vaccine development, rationale for human infection studies in semi-immune adults in Kenya, work in progress and future developments
Linda-Gail Bekker, University of Cape Town
Why has HIV vaccine development been so challenging, update on HIV vaccine clinical development, and scientific advances fueling vaccine discovery
Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza
Options for pandemic influenza vaccines and challenges of universal influenza vaccine development
Sarah Gilbert, University of Oxford
Viral-vectored vaccines against Ebola, Chikungunya, and COVID-19
Ann Ginsberg
Recent results in TB vaccine R&D are game-changing: what key challenges and opportunities remain?
Christian Mandl, Sarah Gilbert, Nathalie Garcon, Florian Krammer, Kanta Subbarao, Lynda Stuart
3:28 - Nucleic acid vaccines: Is it all done? Christian Mandl. 21:37 - Viral Vectored vaccine platform technologies, Sarah Gilbert. 33:49 - Adjuvants, . 45:16 - Block 1 Q&A, Christian Mandl, Nathalie...
GVIRF Secretariat
Learnings from COVID-19 and applications to other global health challenges. Topics include how a correlate of protection (CoP) is discovered and applied for vaccine development; identification of a...